Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial

Abstract Background Allergic rhinitis (AR) is a non-infectious immune disease and incidents of the disease has continuously increased in Thailand. Ginger, a Thai herb, is used in food and Thai traditional medicine. This study was designed to assess efficacy and safety of ginger extract in comparison...

Full description

Bibliographic Details
Main Authors: Rodsarin Yamprasert, Waipoj Chanvimalueng, Nichamon Mukkasombut, Arunporn Itharat
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12906-020-2875-z
id doaj-133a9abec1eb48d195c195a7565326a2
record_format Article
spelling doaj-133a9abec1eb48d195c195a7565326a22020-11-25T03:02:43ZengBMCBMC Complementary Medicine and Therapies2662-76712020-04-0120111110.1186/s12906-020-2875-zGinger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trialRodsarin Yamprasert0Waipoj Chanvimalueng1Nichamon Mukkasombut2Arunporn Itharat3Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat UniversityDepartment of Otolaryngology, Faculty of Medicine, Thammasat UniversityDepartment of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat UniversityDepartment of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat UniversityAbstract Background Allergic rhinitis (AR) is a non-infectious immune disease and incidents of the disease has continuously increased in Thailand. Ginger, a Thai herb, is used in food and Thai traditional medicine. This study was designed to assess efficacy and safety of ginger extract in comparison with loratadine for AR treatment. Methods AR patients were treated with ginger extract 500 mg (n = 40) against those treated with loratadine 10 mg (n = 40) in a randomized, double-blind, controlled trial for 3 and 6 weeks. The efficacy was evaluated from clinical examinations i.e. total nasal symptom scores (TNSS), cross-sectional area of the nasal cavity with acoustic rhinometry (ARM) and rhinoconjunctivitis quality of life questionnaire (RQLQ). The safety of treatment was measured by blood pressure, blood analysis and history-taking for side effects. Results The results showed both ginger extract and loratadine treated groups significantly decreased TNSS scores but there was no significant difference between the two groups. In acoustic rhinometry measurement, the ginger treated group significantly gradually increased the estimated volume of the nasal cavity and decreased distances from the nostril, but the loratadine treated group did not cause a change. Both groups gave significantly improvement in every aspect of the RQLQ at third weeks. The treatment with ginger extract was as safe as loratadine as shown by renal and liver function results obtained from blood analysis. Both treatments had no effect on blood pressure of the patients. Conclusions The ginger extract is as good as loratadine in improving nasal symptoms and quality of life in AR patients. However, ginger extract caused less side effects especially, drowsiness, fatigue, dizziness and constipation. Therefore, the ginger extract could be used as alternative treatment for patients with AR. Trial registration Registered with ClinicalTrials.gov (Registration number: NCT02576808 ) on 15 October 2015.http://link.springer.com/article/10.1186/s12906-020-2875-zGinger extractLoratadineAllergic rhinitisQuality of lifeClinical trials
collection DOAJ
language English
format Article
sources DOAJ
author Rodsarin Yamprasert
Waipoj Chanvimalueng
Nichamon Mukkasombut
Arunporn Itharat
spellingShingle Rodsarin Yamprasert
Waipoj Chanvimalueng
Nichamon Mukkasombut
Arunporn Itharat
Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial
BMC Complementary Medicine and Therapies
Ginger extract
Loratadine
Allergic rhinitis
Quality of life
Clinical trials
author_facet Rodsarin Yamprasert
Waipoj Chanvimalueng
Nichamon Mukkasombut
Arunporn Itharat
author_sort Rodsarin Yamprasert
title Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial
title_short Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial
title_full Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial
title_fullStr Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial
title_full_unstemmed Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial
title_sort ginger extract versus loratadine in the treatment of allergic rhinitis: a randomized controlled trial
publisher BMC
series BMC Complementary Medicine and Therapies
issn 2662-7671
publishDate 2020-04-01
description Abstract Background Allergic rhinitis (AR) is a non-infectious immune disease and incidents of the disease has continuously increased in Thailand. Ginger, a Thai herb, is used in food and Thai traditional medicine. This study was designed to assess efficacy and safety of ginger extract in comparison with loratadine for AR treatment. Methods AR patients were treated with ginger extract 500 mg (n = 40) against those treated with loratadine 10 mg (n = 40) in a randomized, double-blind, controlled trial for 3 and 6 weeks. The efficacy was evaluated from clinical examinations i.e. total nasal symptom scores (TNSS), cross-sectional area of the nasal cavity with acoustic rhinometry (ARM) and rhinoconjunctivitis quality of life questionnaire (RQLQ). The safety of treatment was measured by blood pressure, blood analysis and history-taking for side effects. Results The results showed both ginger extract and loratadine treated groups significantly decreased TNSS scores but there was no significant difference between the two groups. In acoustic rhinometry measurement, the ginger treated group significantly gradually increased the estimated volume of the nasal cavity and decreased distances from the nostril, but the loratadine treated group did not cause a change. Both groups gave significantly improvement in every aspect of the RQLQ at third weeks. The treatment with ginger extract was as safe as loratadine as shown by renal and liver function results obtained from blood analysis. Both treatments had no effect on blood pressure of the patients. Conclusions The ginger extract is as good as loratadine in improving nasal symptoms and quality of life in AR patients. However, ginger extract caused less side effects especially, drowsiness, fatigue, dizziness and constipation. Therefore, the ginger extract could be used as alternative treatment for patients with AR. Trial registration Registered with ClinicalTrials.gov (Registration number: NCT02576808 ) on 15 October 2015.
topic Ginger extract
Loratadine
Allergic rhinitis
Quality of life
Clinical trials
url http://link.springer.com/article/10.1186/s12906-020-2875-z
work_keys_str_mv AT rodsarinyamprasert gingerextractversusloratadineinthetreatmentofallergicrhinitisarandomizedcontrolledtrial
AT waipojchanvimalueng gingerextractversusloratadineinthetreatmentofallergicrhinitisarandomizedcontrolledtrial
AT nichamonmukkasombut gingerextractversusloratadineinthetreatmentofallergicrhinitisarandomizedcontrolledtrial
AT arunpornitharat gingerextractversusloratadineinthetreatmentofallergicrhinitisarandomizedcontrolledtrial
_version_ 1724688825477758976